3D QSAR studies on GSK-3 inhibition by aloisines

被引:17
|
作者
Zeng, M [1 ]
Jiang, YJ [1 ]
Zhang, B [1 ]
Zheng, KW [1 ]
Zhang, N [1 ]
Yu, QS [1 ]
机构
[1] Zhejiang Univ, Key Lab Mol Design & Nutr Engn, Ningbo Inst Technol, Ningbo 315100, Zhejiang Prov, Peoples R China
关键词
3D-QSAR; GSK-3; aloisines;
D O I
10.1016/j.bmcl.2004.10.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
GSK-3 is involved in various physiological processes and its inhibitors have been evaluated as promising drug candidates for a lot of unmet pathologies. In this paper, inhibition of GSK-3 by aloisines is investigated by 3D QSAR studies. Two alignment rules were applied to check the influence of spatial alignment of the compounds. Both the CoMFA and CoMSIA techniques were carried out and ASS procedure was applied for CoMFA to find a satisfactory model. The best QSAR model obtained is a CoMSIA model characterized with r(2) of 0.938 and q(2) of 0.673 including steric, electrostatic and hydrophobic fields, possessing good predicting ability. To get a better understanding of the relationship between chemical structure and biological activity, a complex structure of aloisine with GSK-3 was obtained by superimposing GSK-3 into the known cocrystal structure of aloisine-CDK2, and then factors that affect the inhibition activity were investigated further, combining the QSAR study with the complex structure, the results of which are in good accordance and complementary to each other. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 50 条
  • [1] 3D QSAR for GSK-3β inhibition by indirubin analogues
    Zhang, N
    Jiang, YJ
    Zou, JW
    Zhang, B
    Jin, HX
    Wang, YH
    Yu, QS
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (03) : 373 - 378
  • [2] Update of QSAR & Docking Studies of the GSK-3 Inhibitors
    Garcia, Isela
    Fall, Yagamare
    Gomez, Generosa
    CURRENT BIOINFORMATICS, 2011, 6 (02) : 215 - 232
  • [3] The choice of atomic charges calculation scheme in 3D-QSAR modelling of GSK-3β inhibition by paullones
    D. I. Osolodkin
    D. A. Shulga
    D. A. Tsareva
    A. A. Oliferenko
    V. A. Palyulin
    N. S. Zefirov
    Doklady Biochemistry and Biophysics, 2010, 434 : 274 - 278
  • [4] The choice of atomic charges calculation scheme in 3D-QSAR modelling of GSK-3β inhibition by paullones
    Osolodkin, D. I.
    Shulga, D. A.
    Tsareva, D. A.
    Oliferenko, A. A.
    Palyulin, V. A.
    Zefirov, N. S.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2010, 434 (01) : 274 - 278
  • [5] Inhibition of GSK-3 by lithium
    Hedgepeth, C
    Conrad, LJ
    Klein, PS
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 106S - 106S
  • [6] Novel Reporter Alleles of GSK-3α and GSK-3β
    Barrell, William B.
    Szabo-Rogers, Heather L.
    Liu, Karen J.
    PLOS ONE, 2012, 7 (11):
  • [7] Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones
    Kunick, C
    Lauenroth, K
    Wieking, K
    Xie, X
    Schultz, C
    Gussio, R
    Zaharevitz, D
    Leost, M
    Meijer, L
    Weber, A
    Jorgensen, FS
    Lemcke, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) : 22 - 36
  • [8] Inhibition of GSK-3β reduces infarct size
    Imahashi, K
    Tong, HY
    Steenbergen, C
    Murphy, E
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (07) : A35 - A35
  • [9] Theoretical study of GSK-3α: neural networks QSAR studies for the design of new inhibitors using 2D descriptors
    Garcia, Isela
    Fall, Yagamare
    Garcia-Mera, Xerardo
    Prado-Prado, Francisco
    MOLECULAR DIVERSITY, 2011, 15 (04) : 947 - 955
  • [10] Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
    Darrington, R. Siobhan
    Campa, Victor M.
    Walker, Marjorie M.
    Bengoa-Vergniory, Nora
    Gorrono-Etxebarria, Irantzu
    Uysal-Onganer, Pinar
    Kawano, Yoshiaki
    Waxman, Jonathan
    Kypta, Robert M.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (06) : E872 - E883